Literature DB >> 20944177

Psychological response to cancer: role of 5-HTTLPR genetic polymorphism of serotonin transporter.

Giulia Schillani1, Elisabetta Martinis, Maria Anna Capozzo, Daniel Era, Tania Cristante, Giorgio Mustacchi, Maria Anna Conte, Maurizio DE Vanna, Luigi Grassi, Tullio Giraldi.   

Abstract

BACKGROUND: 5-HTTLPR genetic polymorphism of serotonin transporter (SERT) and stressful life events facilitate depression. The aim of this investigation was therefore to determine the correlations between SERT polymorphism and mental adjustment to cancer. PATIENTS AND METHODS: Breast cancer patients early after surgery, and subjects with various advanced tumours were recruited, evaluated using the Mini Mental Adjustment to Cancer Scale and Hospital Anxiety and Depression Scale (HADS), and genotyped.
RESULTS: In early breast cancer patients (n=53), hopelessness-helplessness (HH) and anxious preoccupation (AP) significantly correlated with depression and anxiety; avoidance (AV) correlated with anxiety. Advanced cancer patients (n=73) displayed similar correlations, and a negative correlation of HADS depression with fighting spirit (FS) and AV. The stratification for 5-HTTLPR showed that early breast cancer carriers of the L/L variant displayed a significant correlation between HH and depression.
CONCLUSION: Among early breast cancer patients, a specific set, characterized by their 5-HTTLPR variant, display differential correlations between HH and depression, with possible implications for treatment options.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944177

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy.

Authors:  Christine Miaskowski; Bruce A Cooper; Michelle Melisko; Lee-May Chen; Judy Mastick; Claudia West; Steven M Paul; Laura B Dunn; Brian L Schmidt; Marilyn Hammer; Frances Cartwright; Fay Wright; Dale J Langford; Kathryn Lee; Bradley E Aouizerat
Journal:  Cancer       Date:  2014-05-02       Impact factor: 6.860

2.  Translational genomic research: the role of genetic polymorphisms in MBSR program among breast cancer survivors (MBSR[BC]).

Authors:  Jong Y Park; Cecile A Lengacher; Richard R Reich; Carissa B Alinat; Sophia Ramesar; Alice Le; Carly L Paterson; Michelle L Pleasant; Hyun Y Park; John Kiluk; Hyo Han; Roohi Ismail-Khan; Kevin E Kip
Journal:  Transl Behav Med       Date:  2019-07-16       Impact factor: 3.626

3.  Post-traumatic Stress Symptoms and Serotonin Transporter (5-HTTLPR) Polymorphism in Breast Cancer Patients.

Authors:  Luigi Zerbinati; Martino Belvederi Murri; Rosangela Caruso; Maria Giulia Nanni; Wendy Lam; Silvia De Padova; Silvana Sabato; Tatiana Bertelli; Giulia Schillani; Tullio Giraldi; Richard Fielding; Luigi Grassi
Journal:  Front Psychiatry       Date:  2021-04-21       Impact factor: 4.157

4.  Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer.

Authors:  Yunxiang Tang; Ruike Zhang; Yinan Li; Shuyu Xu; Hao Wang; Jingzhou Xu; Lei Xiao; Yajing Wang; Jing Du; Yujia Huang; Tong Su
Journal:  BMC Cancer       Date:  2021-07-21       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.